Home ›
Trademark Categories ›
Pharmaceuticals ›
2022 ›
AD ›
AD04
Trademark search for:
AD04
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-12-21 — Application filed
2023-01-19 — Sn assigned for sect 66a appl from ib
2023-01-20 — Application filed
2023-01-24 — Application filed
2023-09-22 — Assigned to examiner
2023-10-03 — Final disposition recorded
2023-10-04 — Office action issued
2023-10-18 — Office action issued
2023-10-18 — Office action issued
2023-11-04 — New representative at ib received
2023-11-07 — Office action issued
2024-06-17 — Notification of possible opposition created, to be sent to ib
2024-06-18 — Notification of possible opposition sent to ib
2024-07-08 — Notification of possible opposition - processed by ib
2024-08-14 — Application abandoned
2024-08-14 — Application abandoned
2024-08-14 — Final status recorded
Owner Information
ADvantage Therapeutics GmbH
AT
Correspondent
SONN Patentanwälte OG Riemergasse 14 A-1010 Wien, AUSTRIA
Filing Details
Filing Date:
2022-12-21
Status Date:
2024-08-14
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.